Wound Care (Pharmacies) - ASEAN

  • ASEAN
  • Revenue in the Wound Care market is projected to reach US$74.10m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.76%, resulting in a market volume of US$76.96m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.11 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in ASEAN is experiencing significant growth and development due to various factors. Customer preferences in the region are shifting towards more advanced wound care products and treatments. There are also several trends in the market that are contributing to its growth. Additionally, there are local special circumstances and underlying macroeconomic factors that are driving the development of the market. Customer preferences in the ASEAN region are increasingly focused on advanced wound care products and treatments. As healthcare standards and awareness improve, consumers are becoming more conscious about the quality of wound care products they use. They are seeking products that can promote faster healing and provide better pain relief. This shift in preferences is driving the demand for innovative wound care solutions in pharmacies across ASEAN countries. One of the trends in the market is the increasing adoption of advanced wound dressings. These dressings are designed to provide better wound management and promote faster healing. They offer benefits such as moisture control, infection prevention, and improved patient comfort. The demand for these dressings is growing as healthcare professionals and patients recognize their effectiveness. Pharmacies in ASEAN are stocking a wider range of advanced wound dressings to cater to this increasing demand. Another trend in the market is the rise in demand for wound care products with natural and organic ingredients. Consumers are becoming more conscious about the potential side effects of synthetic ingredients and are seeking products that are gentler on the skin. This trend is particularly prominent in countries with a strong focus on natural and traditional medicine, such as Indonesia and Thailand. Pharmacies in these countries are responding to this trend by stocking natural and organic wound care products. Local special circumstances also play a role in the development of the Wound Care (Pharmacies) market in ASEAN. For example, in countries with a high prevalence of diabetes, such as Malaysia and Singapore, there is a greater demand for wound care products that are specifically designed for diabetic foot ulcers. Pharmacies in these countries are stocking a wide range of diabetic wound care products to cater to this specific need. Underlying macroeconomic factors also contribute to the growth of the market. As the ASEAN region continues to experience economic growth, there is an increase in disposable income and healthcare spending. This allows consumers to afford higher quality wound care products and treatments. Additionally, the growing aging population in ASEAN countries is driving the demand for wound care products, as older individuals are more prone to chronic wounds and require specialized care. In conclusion, the Wound Care (Pharmacies) market in ASEAN is developing rapidly due to shifting customer preferences, various market trends, local special circumstances, and underlying macroeconomic factors. The demand for advanced wound care products, natural and organic ingredients, and diabetic wound care products is driving the growth of the market. As the region continues to experience economic growth and an aging population, the market is expected to further expand in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)